Balis, Marjorie M.

HRN: 27-03-43  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/14/2025
09/24/2025
IV
4.5g
Q6HRS
T/C ILEOCECAL ADENOCARCINOMA
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: